Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MARK SMITH

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1861479651
CMS profile
220765
Location
ANCHORAGE, AK

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$78,872.59

105 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

By paying entity

PY2022 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 105 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MARK SMITH

NPI 1861479651 · CMS profile ID 220765

Allopathic & Osteopathic Physicians / Internal Medicine / Nephrology

ANCHORAGE, AK

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 105 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1861479651?year=2022&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MARK SMITH, NPI 1861479651, CMS profile ID 220765. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 105 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1861479651?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). MARK SMITH, NPI 1861479651, CMS profile ID 220765. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 105 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1861479651?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
MARK SMITH, NPI 1861479651, CMS profile ID 220765, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 105 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1861479651?year=2022&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

105 matching records · $78,872.59 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 105 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 105.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Travere Therapeutics, Inc. $2.4905/12/2022 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 960076623 CMS
Travere Therapeutics, Inc. $14.2905/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 960076625 CMS
Amgen Inc. $25.4605/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 933768531 CMS
Vifor Pharma, Inc. $69.8505/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 896757681 CMS
Vifor Pharma, Inc. $485.0505/03/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 896757689 CMS
Bayer HealthCare Pharmaceuticals Inc. $2,775.0004/28/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930227925 CMS
Bayer HealthCare Pharmaceuticals Inc. $15.6204/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930007219 CMS
Bayer HealthCare Pharmaceuticals Inc. $3,330.0004/21/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929991819 CMS
Bayer HealthCare Pharmaceuticals Inc. $1,805.0004/21/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929997433 CMS
Bayer HealthCare Pharmaceuticals Inc. $2,775.0004/18/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930332613 CMS
Bayer HealthCare Pharmaceuticals Inc. $27.3704/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930163743 CMS
Bayer HealthCare Pharmaceuticals Inc. $2,775.0004/11/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930190343 CMS
Bayer HealthCare Pharmaceuticals Inc. $2,775.0004/11/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930322065 CMS
Bayer HealthCare Pharmaceuticals Inc. $22.5603/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930031359 CMS
Bayer HealthCare Pharmaceuticals Inc. $2,775.0003/28/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930014867 CMS
Bayer HealthCare Pharmaceuticals Inc. $2,775.0003/28/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930072783 CMS
Bayer HealthCare Pharmaceuticals Inc. $3,330.0003/28/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930076201 CMS
Bayer HealthCare Pharmaceuticals Inc. $2,775.0003/28/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930079683 CMS
Bayer HealthCare Pharmaceuticals Inc. $1,110.0003/28/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930302185 CMS
Bayer HealthCare Pharmaceuticals Inc. $28.3403/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929945515 CMS
Bayer HealthCare Pharmaceuticals Inc. $2,775.0003/21/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929961517 CMS
Bayer HealthCare Pharmaceuticals Inc. $3,330.0003/21/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930058337 CMS
Bayer HealthCare Pharmaceuticals Inc. $3,330.0003/21/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930213065 CMS
Bayer HealthCare Pharmaceuticals Inc. $771.8703/16/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929991935 CMS
Bayer HealthCare Pharmaceuticals Inc. $125.0003/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930029009 CMS
Bayer HealthCare Pharmaceuticals Inc. $25.4503/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930155003 CMS
Bayer HealthCare Pharmaceuticals Inc. $12.9103/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930019733 CMS
Bayer HealthCare Pharmaceuticals Inc. $125.0003/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930123675 CMS
Bayer HealthCare Pharmaceuticals Inc. $9.3603/10/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929873349 CMS
Bayer HealthCare Pharmaceuticals Inc. $149.7603/10/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930014469 CMS
Bayer HealthCare Pharmaceuticals Inc. $1,110.0003/09/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930026355 CMS
Vifor Pharma, Inc. $4.1403/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 896757701 CMS
Alexion Pharmaceuticals, Inc. $13.2603/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915409735 CMS
Bayer HealthCare Pharmaceuticals Inc. $17.0703/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930180313 CMS
Horizon Therapeutics plc $11.8503/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937698949 CMS
Aurinia Pharma U.S., Inc. $17.1303/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954104721 CMS
Bayer HealthCare Pharmaceuticals Inc. $4.2202/25/2022 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929879631 CMS
Bayer HealthCare Pharmaceuticals Inc. $3,885.0002/24/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930227931 CMS
CALLIDITAS THERAPEUTICS US INC. $18.9902/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 927061023 CMS
Bayer HealthCare Pharmaceuticals Inc. $125.0002/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930079471 CMS
Bayer HealthCare Pharmaceuticals Inc. $18.8102/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930030759 CMS
Bayer HealthCare Pharmaceuticals Inc. $111.5102/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930030767 CMS
Bayer HealthCare Pharmaceuticals Inc. $1,083.0002/10/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930052343 CMS
GlaxoSmithKline, LLC. $12.8802/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944578549 CMS
Takeda Pharmaceuticals U.S.A., Inc. $28.8402/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 955833155 CMS
Bayer HealthCare Pharmaceuticals Inc. $24.1802/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930005741 CMS
Bayer HealthCare Pharmaceuticals Inc. $14.3802/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930120437 CMS
Bayer HealthCare Pharmaceuticals Inc. $18.1401/31/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930225671 CMS
Fresenius USA Marketing, Inc. $14.5901/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954583645 CMS
Bayer HealthCare Pharmaceuticals Inc. $2,775.0001/20/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930298431 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,201.93 26
PY2020 $370.51 22
PY2021 $14,814.64 65
PY2022 $78,872.59 105
PY2023 $24,152.07 75
PY2024 $7,046.39 35
PY2025 $23,927.87 56

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $20,787.50 5
PY2024 Recipient $2,136.78 4
PY2024 Principal investigator $51,459.39 12
PY2023 Recipient $5,327.79 6
PY2023 Principal investigator $78,259.98 12
PY2022 Principal investigator $81,456.45 11
PY2021 Principal investigator $9,289.49 55
PY2020 Principal investigator $146,155.02 27
PY2019 Principal investigator $72,544.97 22

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

5 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $3,895.44 05/30/2025 Non-covered Recipient Entity
Southeastern Clinical Research Institute Llc
A randomized, double-blind, placebo-controlled, parallel-group, multicenter Phase 3 study to investigate the efficacy and safety of FInerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic K No dispute reported 06/30/2026 1225412624
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $3,338.43 05/05/2025 Non-covered Recipient Entity
Southeastern Clinical Research Institute Llc
A randomized, double-blind, placebo-controlled, parallel-group, multicenter Phase 3 study to investigate the efficacy and safety of FInerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic K No dispute reported 06/30/2026 1225412848
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $5,269.00 03/27/2025 Non-covered Recipient Entity
Southeastern Clinical Research Institute Llc
BAY 948862, A randomised, double-blind, placebo-controlled, parallel-group, multicentre Phase 3 study to investigate the efficacy and safety of Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic No dispute reported 06/30/2026 1225406062
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $4,853.79 03/06/2025 Non-covered Recipient Entity
Southeastern Clinical Research Institute Llc
BAY 948862, A randomised, double-blind, placebo-controlled, parallel-group, multicentre Phase 3 study to investigate the efficacy and safety of Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic No dispute reported 06/30/2026 1225406094
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $3,430.84 01/28/2025 Non-covered Recipient Entity
Southeastern Clinical Research Institute Llc
BAY 948862, A randomised, double-blind, placebo-controlled, parallel-group, multicentre Phase 3 study to investigate the efficacy and safety of Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic No dispute reported 06/30/2026 1225404010